These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29684085)

  • 1. The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency.
    Li Z; Mbonye U; Feng Z; Wang X; Gao X; Karn J; Zhou Q
    PLoS Pathog; 2018 Apr; 14(4):e1007012. PubMed ID: 29684085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
    Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M
    Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.
    Mbonye UR; Gokulrangan G; Datt M; Dobrowolski C; Cooper M; Chance MR; Karn J
    PLoS Pathog; 2013; 9(5):e1003338. PubMed ID: 23658523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat.
    Liang T; Zhang Q; Wu Z; Chen P; Huang Y; Liu S; Li L
    mBio; 2021 Aug; 12(4):e0162521. PubMed ID: 34465029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.
    Li Z; Guo J; Wu Y; Zhou Q
    Nucleic Acids Res; 2013 Jan; 41(1):277-87. PubMed ID: 23087374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
    Abner E; Stoszko M; Zeng L; Chen HC; Izquierdo-Bouldstridge A; Konuma T; Zorita E; Fanunza E; Zhang Q; Mahmoudi T; Zhou MM; Filion GJ; Jordan A
    J Virol; 2018 May; 92(10):. PubMed ID: 29343578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal.
    Cisneros WJ; Soliman SHA; Walter M; Simons LM; Cornish D; De Fabritiis S; Halle AW; Kim EY; Wolinsky SM; Lorenzo-Redondo R; Shilatifard A; Hultquist JF
    PLoS Pathog; 2024 Sep; 20(9):e1012083. PubMed ID: 39259751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Natural Product from Polygonum cuspidatum Sieb. Et Zucc. Promotes Tat-Dependent HIV Latency Reversal through Triggering P-TEFb's Release from 7SK snRNP.
    Wang C; Yang S; Lu H; You H; Ni M; Shan W; Lin T; Gao X; Chen H; Zhou Q; Xue Y
    PLoS One; 2015; 10(11):e0142739. PubMed ID: 26569506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Molecular Basis for Human Immunodeficiency Virus Latency.
    Mbonye U; Karn J
    Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV latency reversing agents act through Tat post translational modifications.
    Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
    Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPI-637 as a Potential Bifunctional Latency-Reversing Agent That Targets Both the BRD4 and TIP60 Proteins.
    Zheng T; Chen P; Huang Y; Qiu J; Zhou C; Wu Z; Li L
    Front Cell Infect Microbiol; 2021; 11():686035. PubMed ID: 34350133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.
    Huang H; Santoso N; Power D; Simpson S; Dieringer M; Miao H; Gurova K; Giam CZ; Elledge SJ; Zhu J
    J Biol Chem; 2015 Nov; 290(45):27297-27310. PubMed ID: 26378236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation.
    Krasnopolsky S; Marom L; Victor RA; Kuzmina A; Schwartz JC; Fujinaga K; Taube R
    Retrovirology; 2019 Jun; 16(1):16. PubMed ID: 31238957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mTOR Complex Controls HIV Latency.
    Besnard E; Hakre S; Kampmann M; Lim HW; Hosmane NN; Martin A; Bassik MC; Verschueren E; Battivelli E; Chan J; Svensson JP; Gramatica A; Conrad RJ; Ott M; Greene WC; Krogan NJ; Siliciano RF; Weissman JS; Verdin E
    Cell Host Microbe; 2016 Dec; 20(6):785-797. PubMed ID: 27978436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of HIV latency.
    Cary DC; Fujinaga K; Peterlin BM
    J Clin Invest; 2016 Feb; 126(2):448-54. PubMed ID: 26731470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-Linked RNA-Binding Motif Protein Modulates HIV-1 Infection of CD4
    Ma L; Jiang QA; Sun L; Yang X; Huang H; Jin X; Zhang C; Wang JH
    mBio; 2020 Apr; 11(2):. PubMed ID: 32317327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome.
    Hokello J; Sharma AL; Tyagi M
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
    Chakraborty S; Kabi M; Ranga U
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
    Mousseau G; Valente ST
    Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.